NCBiotech News

Durham scientist Mansukh Wani, Ph.D., whose career at RTI International brought cancer drugs that saved countless lives, died of natural causes last Saturday at the age of 95.

The U.S. Food and Drug Administration has accepted Liquidia Technologies’ new drug application for its pulmonary arterial hypertension treatment, LIQ861.

An unusual therapy under development by Fennec Pharmaceuticals is getting an expedited opportunity to protect the hearing of children undergoing chemotherapy.

Grid Therapeutics has received clearance from the U.S. Food and Drug Administration to begin human testing of its new cancer immunotherapy.

Durham-based BioCryst Pharmaceuticals will conduct a clinical trial in Brazil to see if its investigational anti-viral drug is effective in treating the COVID-19 coronavirus.

Durham's Arbiom, which is developing technology to convert wood into feed and food, says it has just completed successful trials of its protein product, SylPro, for weanling pig nutrition.

RedHill Biopharma has joined a growing list of companies with North Carolina ties that are seeking solutions to the global coronavirus pandemic.

Women account for a mere 5% of the top leadership of life science companies in North Carolina -- and it's not the only state struggling with that disparity.

Using 3D printers, Morrisville-based Gilero is leading a response to the shortage of COVID-19 protective equipment for healthcare workers.

LabCorp says it’s ahead of schedule in ramping up its capacity to conduct COVID-19 tests, and is now able to perform more than 20,000 of the tests per day.

Lighthouse Lab Services, a medical laboratory consulting, staffing and recruiting company based in Holly Springs, has finalized a merger with Elite Diagnostics, a healthcare consulting and management firm in Charlotte.

Clinical research organization Aperio Clinical Outcomes is the newest tenant in downtown Durham’s progressive American Tobacco Campus.

FUJIFILM Diosynth Biotechnologies U.S.A. has broken ground on a $54 million, 31,778-square-foot expansion of its biomanufacturing facilities in Morrisville.

Alcami Corp., a contract development and manufacturing organization (CDMO) headquartered in Durham and with major operations in Wilmington, has expanded its drug-making capacity by acquiring TriPharm Services.

Burlington-based LabCorp has introduced a suite of cell and gene therapy development services from Covance, its drug development business, to help biopharmaceutical companies develop cell and gene therapies for cancer and other diseases.